| abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: what is presented is using 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or 10-[(3R,3S)-1 -azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or its pharmaceutically acceptable salts for preparing a drug for preventing or treating obstructive bronchopneumopathy characterised by the fact that the drug is presented in the oral form providing an administered dose of 1 mcg/kg to 10 mg/kg, and characterised by the fact that the drug is presented in the form of a solution for oral pulverisation or a powder for inhalation. n EFFECT: invention provides the respiration recovery, specifically respiration rate, and increases an inspiration and expiration flow, reduces an infiltrated neutrophil count and a direct anti-inflammatory effect. n 4 cl, 2 dwg, 10 ex |